- Neutra is expanding its presence in the CBD market, which is now projected to reach $20 billion by 2024
- The majority of CBD product sales are expected to soon occur in general retail stores and online instead of at cannabis dispensaries
- Neutra’s acquisition of VIVIS adds an emerging retail brand of hemp-based health and nutritional products to the company’s portfolio
- Its acquisition of J3 Holdings includes land, a warehouse and licensing to cultivate hemp and refine it into usable forms
Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, has astutely taken advantage of several opportunities as the nation’s exploding CBD market begins to move into the general market retail sector. Two recent acquisitions are expected to accelerate Neutra’s corporate vision of bringing the highest quality, high potency hemp-based CBD extract products to retail customers.
Neutra’s purchase of VIVIS, an emerging retail brand of hemp-based health and nutritional products, is underway with the signing of a letter of intent (LOI) (http://ibn.fm/VFex6).
“This acquisition will give Neutra Corp. an even stronger market presence with an established brand already recognized for superiority,” Neutra President and CEO Sydney Jim stated in a news release. “VIVIS’ hemp-derived CBD (cannabidiol) products are third-party certified as containment-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, we’re expecting greater interest in the other products we’re bringing to market.”
Leading cannabis researchers BDS Analytics and Arcview Market Research project that the collective market for CBD sales in the U.S. will surpass $20 billion by 2024, achieving a compound annual growth rate of 49 percent across all distribution channels (http://ibn.fm/Gq1Vc). Interestingly, the report predicts that the majority of CBD product sales will soon occur in general retail stores instead of cannabis dispensaries, as Forbes reported (http://ibn.fm/uee8p). National chains like CVS and Walgreens have announced plans to carry CBD products in some stores, and these offerings are already in several department stores, such as Sephora (http://ibn.fm/3bLqe).
VIVIS is already selling a carefully formulated product that utilizes a 99 percent or higher grade of hemp-extracted crystalline CBD. Each product sold by VIVIS is third-party lab tested for purity and receives a certificate of analysis verifying that it has been produced with the most potent and contaminant-free hemp-extracted CBD (http://ibn.fm/ztpDL).
Neutra’s acquisition of J3 Holdings, which currently owns land, a warehouse and licensing to cultivate hemp and refine it into useable forms, will provide the company with numerous options as it develops into a vertically integrated CBD company, according to a news release (http://ibn.fm/AzLyu).
“This is a big acquisition and a great demonstration of the continued evolution of our company,” Jim added. “This shows we’re moving forward with our plans to become a serious player in the ever-growing CBD market. CBD products are rapidly gaining mainstream acceptance.”
For more information, visit the company’s website at www.NeutraInc.com
NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://ibn.fm/NTRR
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
